Successful Installation of ETH 1.2 GHz NMR System Enables Novel Research Capabilities in Solid-State NMR

ETH Zürich Accepts Bruker 1.2 GHz NMR Spectrometer BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the successful installation and customer acceptance of the Avance™ NEO 1.2 GHz NMR system at the Department of Chemistry and Applied Biosciences of the Eidgenössische Technische Hochschule (ETH) Zürich (www.ethz.ch) in Switzerland. Following the acceptance of the world’s... Read more

QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher

Venlo, the Netherlands, July 22, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the publication of its Supplemental Reasoned Position Statement in response to the amended Offer Document published by Thermo Fisher Scientific Inc (NYSE: TMO) on July 17, 2020. The Offer Document relates to the recommended offer by Thermo Fisher... Read more

Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2

AUSTIN, Texas, July 22, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing. The new test is a combination of the company’s original NxTAG RPP,... Read more

Bio-Techne Announces Launch of Exocovid-19 Test for Detection of SARS-CoV-2 in Patient Samples

MINNEAPOLIS, July 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory. Exosome Diagnostics, the... Read more

PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test

Fully automated kit detects human antibodies of immunoglobulin class IgG to help identify individuals with adaptive immune response WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 21, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP®/DELFIA® platform,... Read more

BD Receives Additional Orders For 177 Million Injection Devices For U.S., Canada COVID-19 Vaccine Preparations

FRANKLIN LAKES, N.J., July 21, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional pandemic orders for needles and syringes from the United States and Canada totaling 177 million injection devices. The new U.S. order for 140 million injection devices brings total U.S. orders from BD... Read more

Xylem announces CFO retirement, appoints Sandra Rowland

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 21, 2020– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced it has appointed Sandra Rowland as Senior Vice President and Chief Financial Officer (CFO), effective October 1, 2020, reporting to Xylem President and Chief Executive Officer Patrick Decker. Rowland... Read more

Bio-Techne Announces Commercial Release of New Assay for Detecting ASOs, miRNAs, and siRNAs in Tissue

Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS, July 20, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with the release of the miRNAscope™ Assay. The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization... Read more